These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 30012132

  • 21. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.
    Hum Vaccin Immunother; 2016 Jul 02; 12(7):1766-76. PubMed ID: 26835890
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS.
    Int J Toxicol; 2005 Jul 02; 24(4):205-13. PubMed ID: 16126614
    [Abstract] [Full Text] [Related]

  • 24. The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Suh J, Lee T, Choi JK, Lee J, Park SH.
    Vaccine; 2021 Apr 28; 39(18):2575-2583. PubMed ID: 33814230
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults.
    McGirr A, Van Oorschot D, Widenmaier R, Stokes M, Ganz ML, Jung H, Varghese L, Curran D.
    Appl Health Econ Health Policy; 2019 Oct 28; 17(5):723-732. PubMed ID: 31250218
    [Abstract] [Full Text] [Related]

  • 30. Effect of universal varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes zoster.
    Shiraki K, Toyama N, Tanaka K, Ito A, Yamamoto J, members of the Miyazaki Dermatologist Society.
    J Dermatol Sci; 2021 Dec 28; 104(3):185-192. PubMed ID: 34836716
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Hornberger J, Robertus K.
    Ann Intern Med; 2006 Sep 05; 145(5):317-25. PubMed ID: 16954357
    [Abstract] [Full Text] [Related]

  • 32. Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review.
    Hodgkinson B, Wang T, Byrnes J, Scuffham P.
    Vaccine; 2021 Mar 01; 39(9):1370-1382. PubMed ID: 33551300
    [Abstract] [Full Text] [Related]

  • 33. The cost-effectiveness of varicella vaccination in Canada.
    Brisson M, Edmunds WJ.
    Vaccine; 2002 Jan 15; 20(7-8):1113-25. PubMed ID: 11803072
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.
    Rev Epidemiol Sante Publique; 2008 Oct 15; 56(5):323-31. PubMed ID: 18951741
    [Abstract] [Full Text] [Related]

  • 36. Cost effectiveness of herpes zoster vaccine in Canada.
    Najafzadeh M, Marra CA, Galanis E, Patrick DM.
    Pharmacoeconomics; 2009 Oct 15; 27(12):991-1004. PubMed ID: 19908924
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E, Uhart M, Böhm K, Aidelsburger P, Anger D, Bianic F, Largeron N.
    Hum Vaccin Immunother; 2015 Oct 15; 11(4):884-96. PubMed ID: 25933182
    [Abstract] [Full Text] [Related]

  • 39. Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States.
    Harpaz R.
    Expert Rev Vaccines; 2019 Aug 15; 18(8):793-811. PubMed ID: 31318605
    [Abstract] [Full Text] [Related]

  • 40. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
    Choi JK, Park SH, Park S, Choi SM, Kim SH, Lee DG, Yoo JH, Choi JH, Kang JH.
    Hum Vaccin Immunother; 2019 Aug 15; 15(11):2554-2560. PubMed ID: 31008679
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.